complement 2015(1).pdf

Upload: setiawan-donnie

Post on 07-Jul-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/18/2019 complement 2015(1).pdf

    1/31

    Dr. Pratiwi S Gunawan, drg.,MKes.,PAH(K)

  • 8/18/2019 complement 2015(1).pdf

    2/31

  • 8/18/2019 complement 2015(1).pdf

    3/31

    Complement was discovered by Jules Bordet as aheat-labile component of normal plasma thatcauses the opsonisation and killing of bacteria.

    The complement system refers to a series of >20proteins, circulating in the blood and tissue fluids.

  • 8/18/2019 complement 2015(1).pdf

    4/31

    Most of the proteins are normally inactive, but in responseto the recognition of molecular components ofmicroorganisms they become sequentially activated in anenzyme cascade – the activation of one protein

    enzymatically cleaves and activates the next protein in thecascade.

  • 8/18/2019 complement 2015(1).pdf

    5/31

    Complement can be activated via three different pathways(Figure 1), which can each cause the activation of C3,cleaving it into a large fragment, C3b, that acts as anopsonin, and a small fragment C3a (anaphylatoxin) that

    promotes inflammation. Activated C3 can trigger the lyticpathway , which can damage the plasma membranes ofcells and some bacteria. C5a, produced by this process,attracts macrophages and neutrophils and also activates

    mast cells.

  • 8/18/2019 complement 2015(1).pdf

    6/31

    Continued next page…

    Classical Pathway  Alternative PathwayMannose Binding Lectin (MBL)

    Pathway

     Antigen-Antibody complex Activating surfaces Pathogen surfaces

    C1

    C4

    C2

    C3b C4

    C2

    MBL

    MASP-1

    MASP-2

    C3 Convertase

    C3b

    C3b

    C3a

    C3

    C5b-9

    C5aC5

    C5 Convertase

    Lytic Pathway

    C5bC6C7C8C9

    Membrane attack complex (MAC)

     Anaphylatoxin

     Activates mast cells

    Chemotactic

    Factor B

    Factor DFactor H

    Factor I

  • 8/18/2019 complement 2015(1).pdf

    7/31

    There are 3 major pathways1. Classical pathway   triggered when IgM or certain

    subclassed of IgG ( IgG1 & IgG3 )

    2.  Alternative pathway  

    triggered when abreakdown product of C3 hydrolis ( C3b ) isdeposited on the surface of microbe

     3. Lectin pathway   initiated in the absence of  

    antibody by the attachment of plasma mannose-binding lectin ( MBL ) to microba

  • 8/18/2019 complement 2015(1).pdf

    8/31

  • 8/18/2019 complement 2015(1).pdf

    9/31

     A) Classical pathway:

    - Complement is activated by antigen –antibody

    complex (IgM or IgG)

    - Fc portion of the antibody form a binding site for C1q

    - The numerical sequence of the complement factors in theclassic pathway is:

    C1q,r,s , C4, C2, C3, C5, C6, C7, C8, C9

  • 8/18/2019 complement 2015(1).pdf

    10/31

    The reaction sequence divided into three

    stages:1) Recognition stage:

    - C1q act as the recognition element- It binds to Fc portion of IgM or IgG- The activated C1 molecule can cleave many C4

    molec.

    2) Activation stage:The complement components C4, C2, C3, C5, C6,C7,

    C8, C9 participate in that order

    3) Membrane attack stage:Complement components C5, C6, C7, C8, C9participate where cell membrane damage and cell

    lysis occur

  • 8/18/2019 complement 2015(1).pdf

    11/31

    This pathway is initiated by:

    * Bacterial endotoxin, polysaccharide capsule,aggregates of IgE and properdin

    * It starts at C3 then C5, C6, C7, C8, C9

    * The complement compon. C1, C4, C2 are by-passed

    * Antibodies are not required to initiateactivation of

    this pathway 

    * This pathway provides a means of non-specificresistance

  • 8/18/2019 complement 2015(1).pdf

    12/31

    Classical Pathway  C1

    C4 C2

    C3  Alternative pathway 

    C5

    C6

    C7

    C8

    C9

    Membrane damage

  • 8/18/2019 complement 2015(1).pdf

    13/31

    Classic Pathway Alternative pathway 

    * Specific acquired immunity * Non-specific innate immunity 

    * Initiated by antibody * Bacterial endotoxin, capsule

    * Interaction of all components * C1, C4, C2 are by-passed

    * Properdin system not involved * Properdin system is involved

  • 8/18/2019 complement 2015(1).pdf

    14/31

  • 8/18/2019 complement 2015(1).pdf

    15/31

    2) Opsonization:

    - binding of complement proteins opsonin (C3b)

    to surfaces of foreign organisms or particles

    - Phagocytic cells express specific receptors for

    opsonins, so promote phagocytosis

  • 8/18/2019 complement 2015(1).pdf

    16/31

    3) Inflammatory response :

    Small fragments released during complement

    activation have several inflammatory actions:

    a) C5a is chemotactic and attract neutrophiles andmacrophages

    b) C5a activate phagocytes and neutrophils

    C) C3,C4 and C5 are anaphylatoxins

    Cause degranulation of mast cells and release of

    histamine and other inflammatory mediators

  • 8/18/2019 complement 2015(1).pdf

    17/31

    4) Immune complex clearance:- C3b facilitate binding of immune complex to severalsurfaces (erythrocytes) and enhance removal by liver

    and spleen

    - binds erythrocytes to blood vessels , make them as

    easy prey for phagocytosis

    - C3 deficiency associated with Immunocomplex

    disease and susceptibility to recurrent infections

  • 8/18/2019 complement 2015(1).pdf

    18/31

    5-Enhancement of antibody production:

    - Binding of C3b to its receptors on activated B cells

    (CR2) greatly enhances antibody production

    - Patient who are deficient in C3b produce

    much less antibody than normal individuals and

    more susceptible to pyogenic infection

  • 8/18/2019 complement 2015(1).pdf

    19/31

  • 8/18/2019 complement 2015(1).pdf

    20/31

    Harmful effects:

    - If complement activate systematically on a largescale (Cm – ve bacilli)

    - If activated by an autoimmune response to host cells

  • 8/18/2019 complement 2015(1).pdf

    21/31

    The complement system plays a critical role ininflammation and defence against some bacterialinfections. Complement may also be activatedduring reactions against incompatible blood

    transfusions, and during the damaging immuneresponses that accompany autoimmune disease.Deficiencies of individual complementcomponents or inhibitors of the system can lead to

    a variety of diseases (Table ), which gives someindication of their role in protection againstdisease

  • 8/18/2019 complement 2015(1).pdf

    22/31

    Complement Deficiency Disease

    C3 and Factor B Severe bacterial infections

    C3b-INA, C6 and C8 Severe Neisseria infections

    Deficiencies of early C components C1, C4, C2. Systemic lupus erythematosus (SLE),

    glomerulonephritis and polymyositis

    C1-inhibitor Hereditary angioedema

  • 8/18/2019 complement 2015(1).pdf

    23/31

  • 8/18/2019 complement 2015(1).pdf

    24/31

  • 8/18/2019 complement 2015(1).pdf

    25/31

  • 8/18/2019 complement 2015(1).pdf

    26/31

  • 8/18/2019 complement 2015(1).pdf

    27/31

  • 8/18/2019 complement 2015(1).pdf

    28/31

  • 8/18/2019 complement 2015(1).pdf

    29/31

  • 8/18/2019 complement 2015(1).pdf

    30/31

  • 8/18/2019 complement 2015(1).pdf

    31/31

    Thanks